1. Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2016.50
Figure 3 Responder rates in studies evaluating reflux inhibitors, either as monotherapy or as an add-on to acid suppressive therapy, for rGERD
Figure 3 | Responder rates in studies evaluating reflux inhibitors, either as monotherapy or as an add-on to acid suppressive therapy, for rGERD. For Vakil et al.100 the left-hand yellow bars represent analysis of the entire population and the right-hand green bars represent analysis of the patients excluding those with mild or very mild symptoms. *P <0.05 compared with respective placebo group. rGERD, refractory GERD.
Scarpellini, E. et al. (2016) Management of refractory typical GERD symptoms
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro